Microbiota I-Centre (MagIC)
Just as Magic is science yet to be discovered, the Microbiota I-Center (MagIC) harnesses and translates the human microbiome into cutting-edge innovations for early disease detection and prevention.
MagIC focuses on advancing science in the gut microbiome and promoting entrepreneurship. It is committed to developing a novel class of microbiome diagnostics and live biotherapeutics for common diseases including obesity, cancer, autism, inflammatory disorders and COVID-19, that will not only transform lives of patients and their families, but also accelerate Hong Kong into a world-class microbiome biotechnology hub.
MagIC advances gut microbiome research for improved treatment outcomes
MagIC advances gut microbiome research for improved treatment outcomes
The centre’s technology has driven stool transplant therapy’s success rate to over 90%.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy